Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Clinical Trial of Randomized, Blinded, Positive-controlled to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.

NCT06305104 is registered in ClinicalTrials.gov with Chengdu CoenBiotech Co., Ltd as lead sponsor.

NCT NCT06305104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06305104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Clinical Trial of Randomized, Blinded, Positive-controlled to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.
Lead sponsor
Chengdu CoenBiotech Co., Ltd
Phase
Phase 2
Overall status
Unknown status
Start date
July 18, 2023
Completion date
June 30, 2024
Enrollment
420 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis